Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CCK-8-Immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian

J M Studler, F Javoy-Agid, F Cesselin

    Brain Research
    |July 8, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study.

    HIV medicine·2014
    Same author

    Determinants of patient satisfaction regarding pain care.

    Revue d'epidemiologie et de sante publique·2012
    Same author

    Autoradiography of CCK receptors in the rat brain using [(3)H]Boc[Nle(28)(31)]CCK(27)-(33) and [(125)I]bolton-hunter CCK(8). Functional significance of subregional distributions.

    Neurochemistry international·2010
    Same author

    Simultaneous evaluation of mRNAs of dopamine ?-hydroxylase, tyrosine hydroxylase and proenkephalin a from three human pheochromocytomas.

    Neurochemistry international·2010
    Same author

    Alterations in central neurotransmitter receptor binding sites following estradiol implantation in female rats.

    Neurochemistry international·2010
    Same author

    Studies on the presence of insulin in rat brain.

    Neurochemistry international·2010
    Same journal

    Targeting neurodevelopmental miR132-3p promotes neuroprotection and axon regeneration after optic nerve injury in mice.

    Brain research·2026
    Same journal

    Variability in acoustic startle response and prepulse inhibition across adulthood in Fragile X messenger ribonucleoprotein 1 knockout mice.

    Brain research·2026
    Same journal

    Transcriptome-guided modeling reveals insulin-related metabolic dysfunction in SCA3 mouse cerebellum.

    Brain research·2026
    Same journal

    Intranasal stromal cell-derived factor-1α mitigates parkinsonian deficits via dual modulation of neuroinflammation and gut microbiota in MPTP-induced models.

    Brain research·2026
    Same journal

    Emotions, the amygdala, and the right hemisphere.

    Brain research·2026
    Same journal

    Electroacupuncture treatment enhances hippocampal growth hormone level and restores mitochondrial function in vascular dementia rats.

    Brain research·2026
    See all related articles

    This study investigated cholecystokinin-8 (CCK-8) levels in Parkinson's disease brains. CCK-8 levels decreased only in the substantia nigra, suggesting most degenerated dopamine neurons may not contain CCK-8.

    Area of Science:

    • Neuroscience
    • Neurochemistry
    • Parkinson's Disease Research

    Background:

    • Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting dopaminergic neurons.
    • Cholecystokinin-8 (CCK-8) is a peptide found in the brain, and its relationship with dopamine in PD is not fully understood.

    Purpose of the Study:

    • To investigate the regional distribution of immunoassayable CCK-8 in the human brain in control and Parkinsonian subjects.
    • To examine the potential coexistence of CCK-8 with dopamine in specific brain regions affected by Parkinson's disease.

    Main Methods:

    • Immunoassayable CCK-8 levels were measured in 12 distinct brain regions from control and Parkinsonian human brains.
    • Specific attention was paid to regions with known dopaminergic projections.

    Related Experiment Videos

    Main Results:

    • CCK-8-I levels were significantly decreased only in the substantia nigra of Parkinsonian brains.
    • No significant decrease in CCK-8-I levels was observed in striatal and corticolimbic dopamine-projecting areas.

    Conclusions:

    • The findings suggest that the majority of dopaminergic neurons that degenerate in Parkinson's disease may not contain the CCK-8 peptide.
    • This indicates a potential dissociation between CCK-8 and dopamine in the pathophysiology of Parkinson's disease, particularly in affected neuronal populations.